CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. [electronic resource]
Producer: 19970519Description: 2966-74 p. digitalISSN:- 0006-4971
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- analysis
- Adult
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- CD3 Complex -- analysis
- CD56 Antigen -- analysis
- Cell Nucleus -- ultrastructure
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Etoposide -- administration & dosage
- Fatal Outcome
- Female
- Femoral Neoplasms -- drug therapy
- Herpesvirus 4, Human
- Humans
- Idarubicin -- administration & dosage
- Immunophenotyping
- Killer Cells, Natural -- drug effects
- Lymphoma, Large-Cell, Immunoblastic -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Lymphoma, T-Cell -- drug therapy
- Male
- Methylprednisolone -- administration & dosage
- Neoplasm Invasiveness
- Neoplasm Proteins -- analysis
- Neoplastic Stem Cells -- drug effects
- Pelvic Neoplasms -- drug therapy
- Prednisone -- administration & dosage
- Quinine -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.